Skip to main content
. 2023 Jun 26;27:100464. doi: 10.1016/j.phro.2023.100464

Table 2.

Overview of the maximum observed deviations among all the dose DVH points analysed (Dmean and D1cc) for targets and OAR structures. The deviations are reported for the combinations of PSQA methods A-D and patients subgroups (i)-(iv).

QA approach Standard cases

Maximum observed deviation [%]
Air pockets cases
Maximum observed deviation [%]
Lung cases

Maximum observed deviation [%]
Implant cases

Maximum observed deviation [%]
(A) Water 1.0% 7.8% 3.7% 4.9%
(B) Bulk densities 1.5% 1.7% 4.6% 2.2%
(C) Separate NN 1.0% 0.9% 1.9% 1.9%
(D) dCT 1.1% 1.3% 1.8% 1.8%